Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
Pfizer Inc.
Valneva Se (VALN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 763,199 | $3,991,531 | 0.36% | |
| 2. | Millennium Management Israel Englander | 135,223 | $707,216 | 0% | |
| 3. | Ironwood Investment Management Warren Isabelle | 45,064 | $235,685 | +80% | 0.08% |
| 4. | Citadel Investment Group Ken Griffin | 20,294 | $106,138 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,052 | $25,062 | 0% |
News See All
Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes
Shares in biotech Valneva ($VALN) soared over 20% in early trading today after it and partner Pfizer ($PFE) as it moved closer to bringing its Lyme...
Valneva SE (NASDAQ:VALN) Q1 2026 Earnings Call Transcript
Valneva SE (NASDAQ:VALN) Q1 2026 Earnings Call Transcript May 13, 2026 Operator: Good day, and thank you for standing by. Valneva presents its First Quarter 2026 Financial Results.
Guggenheim Cuts PT on Valneva SE (VALN) to $11 From $13
Valneva SE (NASDAQ:VALN) is one of the most undervalued biotech stocks to buy right now.
8 Most Undervalued Biotech Stocks to Buy Right Now
In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now.
8 Most Oversold Strong Buy-Rated Stocks to Invest In
In this article, we will look at the 8 Most Oversold Strong Buy-Rated Stocks to Invest In. Oversold stocks are getting a fresh look in 2026, but not simply because they are down.
Valneva SE (NASDAQ:VALN) Q3 2025 Earnings Call Transcript
Valneva SE (NASDAQ:VALN) Q3 2025 Earnings Call Transcript November 20, 2025Valneva SE misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.3.
Valneva SE (NASDAQ:VALN) Q2 2025 Earnings Call Transcript
Valneva SE (NASDAQ:VALN) Q2 2025 Earnings Call Transcript August 12, 2025 Joshua Drumm: Thank you, operator.
Valneva SE (NASDAQ:VALN) Q1 2025 Earnings Call Transcript
Valneva SE (NASDAQ:VALN) Q1 2025 Earnings Call Transcript May 9, 2025 Joshua Drumm: Thank you. Hello, and thank you for joining us to discuss Valneva's first quarter 2025 results and corporate update.
11 Best Performing NASDAQ Stocks So Far in 2025
On March 29, T. Rowe Price portfolio manager Tony Wang appeared on CNBC’s 'Closing Bell Overtime' to discuss the current volatility in the tech sector, especially the NASDAQ.